Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Capstan Therapeutics

Biotech & Life Sciences · San Diego, United States · Founded 2021 Unicorn

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$1–2.5B
Latest valuation · 2026
Unlock exact value
Headcount
<100
Current team size
Unlock exact value

Investors

16 investors on Capstan Therapeutics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Global footprint

Where Capstan Therapeutics has talent and traffic

Web traffic by country
230 monthly visits
across markets
🇺🇸 United States87%
Top 1 markets shown

Patent intelligence

$108k patent portfolio · 6 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with topic prominence vs same-sector peers.

Estimated portfolio value
$108k
<0.01% of valuation · 43.1× smaller than top peer Orna Therapeutics ($5M)
6 active patent families
Where Capstan Therapeutics innovates NanoparticleMolecular biologyNucleic acidEx vivoCell type

Tech-focus vs peers

Where Capstan Therapeutics concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Capstan Therapeutics and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Capstan Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.